A199800 Stock Overview
A biotechnology company, focuses on the development of genome editing technology in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ToolGen Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩39,050.00 |
| 52 Week High | ₩110,000.00 |
| 52 Week Low | ₩36,100.00 |
| Beta | 1.76 |
| 11 Month Change | -32.09% |
| 3 Month Change | -52.14% |
| 1 Year Change | -40.47% |
| 33 Year Change | -72.65% |
| 5 Year Change | -23.13% |
| Change since IPO | -20.31% |
Recent News & Updates
Would ToolGen (KOSDAQ:199800) Be Better Off With Less Debt?
Nov 19
ToolGen (KOSDAQ:199800) Has Debt But No Earnings; Should You Worry?
Aug 06We Think ToolGen (KOSDAQ:199800) Can Easily Afford To Drive Business Growth
Mar 28Shareholder Returns
| A199800 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -21.1% | -5.8% | -2.8% |
| 1Y | -40.5% | 28.2% | -3.4% |
Return vs Industry: A199800 underperformed the KR Biotechs industry which returned 28.2% over the past year.
Return vs Market: A199800 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A199800 volatility | |
|---|---|
| A199800 Average Weekly Movement | 10.8% |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A199800's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A199800's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 81 | Young Ho Kim | www.toolgen.com |
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses.
ToolGen Incorporated Fundamentals Summary
| A199800 fundamental statistics | |
|---|---|
| Market cap | ₩310.23b |
| Earnings (TTM) | -₩46.64b |
| Revenue (TTM) | ₩1.07b |
289.9x
P/S Ratio-6.7x
P/E RatioIs A199800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A199800 income statement (TTM) | |
|---|---|
| Revenue | ₩1.07b |
| Cost of Revenue | ₩217.82m |
| Gross Profit | ₩852.37m |
| Other Expenses | ₩47.49b |
| Earnings | -₩46.64b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.87k |
| Gross Margin | 79.65% |
| Net Profit Margin | -4,357.79% |
| Debt/Equity Ratio | 310.5% |
How did A199800 perform over the long term?
See historical performance and comparison